Author: "Hoyle M" - OpacWWW - Prolib Integro

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You search for a phrase ""Hoyle M"" according to the criterion: Author

Showing 1-6 from 6 results

Select items

Go to position: 1.

Title:: A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Authors:: Snowsill T; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. t.m..
Huxley N; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Hoyle M; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. m.w.hoyle@exeter.ac.uk.
Jones-Hughes T; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Coelho H; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Cooper C; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .
Frayling I; Institute of Cancer & Genetics, Cardiff University, Cardiff, UK. .
Hyde C; Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK. .; Show more
Source:: BMC cancer [BMC Cancer] 2015 Apr 25; Vol. 15, pp. 313. Date of Electronic Publication: 2015 Apr 25.
Publication Type:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Age of Onset ; Aged ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Cost-Benefit Analysis ; DNA Mutational Analysis ; Decision Making, Computer-Assisted ; Female ; Humans ; Male ; Middle Aged ; Models, Economic ; Molecular Diagnostic Techniques/economics ; Quality-Adjusted Life Years ; Risk ; Sensitivity and Specificity

Academic Journal

in the bookshelf

Full Text Details

Go to position: 2.

Title:: Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer.
Authors:: Joulain F; Sanofi, 1 av. Pierre Brossolette, Chilly Mazarin 91385, France.
Proskorovsky I
Allegra C
Tabernero J
Hoyle M
Iqbal SU
Van Cutsem E; Show more
Source:: British journal of cancer [Br J Cancer] 2013 Oct 01; Vol. 109 (7), pp. 1735-43. Date of Electronic Publication: 2013 Sep 17.
Publication Type:: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Camptothecin/*analogs & derivatives
Colorectal Neoplasms/*drug therapy
Colorectal Neoplasms/*mortality
Receptors, Vascular Endothelial Growth Factor/*therapeutic use
Recombinant Fusion Proteins/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/adverse effects ; Camptothecin/therapeutic use ; Disease-Free Survival ; Drug Resistance, Neoplasm ; Female ; Fluorouracil/adverse effects ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/adverse effects ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Placebos/administration & dosage ; Receptors, Vascular Endothelial Growth Factor/adverse effects ; Recombinant Fusion Proteins/adverse effects ; Survival Rate ; Treatment Outcome ; Young Adult
SCR Protocol:: IFL protocol

Academic Journal

in the bookshelf

Full Text Details

Go to position: 3.

Title:: Historical lifetimes of drugs in England: application to value of information and cost-effectiveness analyses.
Authors:: Hoyle M; Peninsula Technology Assessment Group (PenTAG), Peninsular College of Medicine and Dentistry, University of Exeter, Exeter, UK. martin.hoyle@pms.ac.uk; Show more
Source:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Dec; Vol. 13 (8), pp. 885-92. Date of Electronic Publication: 2010 Sep 03.
Publication Type:: Historical Article; Journal Article
MeSH Terms:: Economics, Pharmaceutical*
Models, Theoretical*
Formularies as Topic/*history
Technology Assessment, Biomedical/*economics
Cost-Benefit Analysis/history ; England ; History, 20th Century ; History, 21st Century ; Humans ; Regression Analysis ; Time Factors

Academic Journal

in the bookshelf

Full Text Details

Go to position: 4.

Title:: Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.
Authors:: Hoyle M; Peninsula Medical School, University of Plymouth, Plymouth, UK. martin.hoyle@pms.ac.uk
Green C
Thompson-Coon J
Liu Z
Welch K
Moxham T
Stein K; Show more
Source:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Jan-Feb; Vol. 13 (1), pp. 55-60. Date of Electronic Publication: 2009 Sep 25.
Publication Type:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*economics
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*economics
Benzenesulfonates/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Pyridines/*economics
Pyridines/*therapeutic use
Carcinoma, Renal Cell/economics ; Chemotherapy, Adjuvant/economics ; Cost-Benefit Analysis ; Decision Support Techniques ; Disease Progression ; Humans ; Kidney Neoplasms/economics ; Markov Chains ; Models, Statistical ; National Health Programs ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Quality-Adjusted Life Years ; Sorafenib ; United Kingdom

Academic Journal

in the bookshelf

Full Text Details

Go to position: 5.

Title:: Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma.
Authors:: Hoyle M; Peninsula Medical School, University of Plymouth, Plymouth, UK. martin.hoyle@pms.ac.uk
Green C
Thompson-Coon J
Liu Z
Welch K
Moxham T
Stein K; Show more
Source:: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2010 Jan-Feb; Vol. 13 (1), pp. 61-8. Date of Electronic Publication: 2009 Sep 25.
Publication Type:: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*economics
Antineoplastic Agents/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Sirolimus/*analogs & derivatives
Carcinoma, Renal Cell/economics ; Cost-Benefit Analysis ; Decision Support Techniques ; Humans ; Immunologic Factors/economics ; Immunologic Factors/therapeutic use ; Interferon-alpha/economics ; Interferon-alpha/therapeutic use ; Kaplan-Meier Estimate ; Kidney Neoplasms/economics ; National Health Programs ; Quality-Adjusted Life Years ; Sirolimus/economics ; Sirolimus/therapeutic use ; United Kingdom

Academic Journal

in the bookshelf

Full Text Details

Go to position: 6.

Title:: Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness.
Authors:: Thompson Coon JS; Peninsula Technology Assessment Group, Peninsula Medical School, Universities of Plymouth and Exeter, Noy Scott House, Barrack Road, Exeter EX2 5DW, UK. />Liu Z
Hoyle M
Rogers G
Green C
Moxham T
Welch K
Stein K; Show more
Source:: British journal of cancer [Br J Cancer] 2009 Jul 21; Vol. 101 (2), pp. 238-43. Date of Electronic Publication: 2009 Jun 30.
Publication Type:: Comparative Study; Journal Article; Review; Systematic Review
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab ; Clinical Trials, Phase III as Topic ; Disease-Free Survival ; Humans ; Indoles/administration & dosage ; Indoles/adverse effects ; Interferon-alpha/administration & dosage ; Interferon-alpha/adverse effects ; Pyrroles/administration & dosage ; Pyrroles/adverse effects ; Randomized Controlled Trials as Topic ; Sunitinib

Academic Journal

in the bookshelf

Full Text Details

Showing 1-6 from 6 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.